87 related articles for article (PubMed ID: 21618347)
1. Classical investigation of incomplete collagen C-propeptide processing reveals a distinctive high bone mass OI phenotype.
Qi M
Hum Mutat; 2011 Jun; 32(6):v. PubMed ID: 21618347
[No Abstract] [Full Text] [Related]
2. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
Pace JM; Chitayat D; Atkinson M; Wilcox WR; Schwarze U; Byers PH
J Med Genet; 2002 Jan; 39(1):23-9. PubMed ID: 11826020
[TBL] [Abstract][Full Text] [Related]
4. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.
Malfait F; Symoens S; Goemans N; Gyftodimou Y; Holmberg E; López-González V; Mortier G; Nampoothiri S; Petersen MB; De Paepe A
Orphanet J Rare Dis; 2013 May; 8():78. PubMed ID: 23692737
[TBL] [Abstract][Full Text] [Related]
5. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.
Cole WG; Chow CW; Bateman JF; Sillence DO
J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680
[TBL] [Abstract][Full Text] [Related]
6. The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues.
Cole WG; Campbell PE; Rogers JG; Bateman JF
J Med Genet; 1990 Sep; 27(9):545-51. PubMed ID: 2121988
[TBL] [Abstract][Full Text] [Related]
7. Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure.
Symoens S; Hulmes DJ; Bourhis JM; Coucke PJ; De Paepe A; Malfait F
Hum Mutat; 2014 Nov; 35(11):1330-41. PubMed ID: 25146735
[TBL] [Abstract][Full Text] [Related]
8. Distinctive skeletal phenotype in high bone mass osteogenesis imperfecta due to a COL1A2 cleavage site mutation.
Nishimura G; Nakajima M; Takikawa K; Haga N; Ikegawa S
Am J Med Genet A; 2016 Aug; 170(8):2212-4. PubMed ID: 27264419
[No Abstract] [Full Text] [Related]
9. Collagen transport and related pathways in Osteogenesis Imperfecta.
Claeys L; Storoni S; Eekhoff M; Elting M; Wisse L; Pals G; Bravenboer N; Maugeri A; Micha D
Hum Genet; 2021 Aug; 140(8):1121-1141. PubMed ID: 34169326
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous C-propeptide mutations in COL1A1: osteogenesis imperfecta type IIC and dense bone variant.
Takagi M; Hori N; Chinen Y; Kurosawa K; Tanaka Y; Oku K; Sakata H; Fukuzawa R; Nishimura G; Spranger J; Hasegawa T
Am J Med Genet A; 2011 Sep; 155A(9):2269-73. PubMed ID: 21834035
[TBL] [Abstract][Full Text] [Related]
11. Defective Proteolytic Processing of Fibrillar Procollagens and Prodecorin Due to Biallelic BMP1 Mutations Results in a Severe, Progressive Form of Osteogenesis Imperfecta.
Syx D; Guillemyn B; Symoens S; Sousa AB; Medeira A; Whiteford M; Hermanns-Lê T; Coucke PJ; De Paepe A; Malfait F
J Bone Miner Res; 2015 Aug; 30(8):1445-56. PubMed ID: 25656619
[TBL] [Abstract][Full Text] [Related]
12. Met>Val substitution in a highly conserved region of the pro-alpha1(I) collagen C-propeptide domain causes alternative splicing and a mild EDS/OI phenotype.
Symoens S; Nuytinck L; Legius E; Malfait F; Coucke PJ; De Paepe A
J Med Genet; 2004 Jul; 41(7):e96. PubMed ID: 15235039
[No Abstract] [Full Text] [Related]
13. COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.
Barnes AM; Ashok A; Makareeva EN; Brusel M; Cabral WA; Weis M; Moali C; Bettler E; Eyre DR; Cassella JP; Leikin S; Hulmes DJS; Kessler E; Marini JC
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2210-2223. PubMed ID: 31055083
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
Tanaka H
Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural and histological findings on examination of skin in osteogenesis imperfecta: a novel study.
Balasubramanian M; Wagner BE; Peres LC; Sobey GJ; Parker MJ; Dalton A; Arundel P; Bishop NJ
Clin Dysmorphol; 2015 Apr; 24(2):45-54. PubMed ID: 25436829
[TBL] [Abstract][Full Text] [Related]
17. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
Galicka A; Wołczyński S; Gindzieński A
Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescent localization of type III collagen and the N-terminal propeptide of type III procollagen in dentin matrix in osteogenesis imperfecta.
Lukinmaa PL
J Craniofac Genet Dev Biol; 1988; 8(3):235-43. PubMed ID: 3062037
[TBL] [Abstract][Full Text] [Related]
19. Osteogenesis imperfecta: Ultrastructural and histological findings on examination of skin revealing novel insights into genotype-phenotype correlation.
Balasubramanian M; Sobey GJ; Wagner BE; Peres LC; Bowen J; Bexon J; Javaid MK; Arundel P; Bishop NJ
Ultrastruct Pathol; 2016; 40(2):71-6. PubMed ID: 26863094
[TBL] [Abstract][Full Text] [Related]
20. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.
Rauch F; Lalic L; Roughley P; Glorieux FH
J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
